The Enterprise Value as of December 2024 (TTM) for Talaris Therapeutics, Inc. (TALS) is 511.85M

According to Talaris Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 511.85M. This represents a change of 25.36% compared to the average of 408.32M of the last 4 quarters.

Talaris Therapeutics, Inc. (TALS) Historical Enterprise Value (quarterly & annually)

How has TALS Enterprise Value performed in the past?

The mean historical Enterprise Value of Talaris Therapeutics, Inc. over the last ten years is 514.07M. The current 511.85M Enterprise Value has changed 9.86% with respect to the historical average. Over the past ten years (40 quarters), TALS's Enterprise Value was at its highest in in the March 2022 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Talaris Therapeutics, Inc. (TALS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Talaris Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Talaris Therapeutics, Inc. (TALS) Average Enterprise Value

How has TALS Enterprise Value performed in the past?

The current Enterprise Value of Talaris Therapeutics, Inc. (TALS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Talaris Therapeutics, Inc. (TALS) Enterprise Value vs. Peers

How is TALS’s Enterprise Value compared to its peers?

Talaris Therapeutics, Inc.’s Enterprise Value is less than Edgewise Therapeutics, Inc. (2.76B), greater than Adicet Bio, Inc. (-12388731.00), less than Cullinan Oncology, Inc. (613.65M), greater than Vor Biopharma Inc. (38.84M), greater than CytomX Therapeutics, Inc. (55.32M), greater than Instil Bio, Inc. (219.18M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Spero Therapeutics, Inc. (-20557187.00), greater than Assembly Biosciences, Inc. (66.94M), less than Nuvation Bio Inc. (893.25M), greater than Achilles Therapeutics plc (-35988955.00), greater than NextCure, Inc. (4.99M), greater than Ovid Therapeutics Inc. (68.41M), greater than Connect Biopharma Holdings Limited (-53600395.00),

Build a custom stock screener for Talaris Therapeutics, Inc. (TALS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talaris Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Talaris Therapeutics, Inc. (TALS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Talaris Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.